Alan S. Wolk
Financieel Directeur/CFO bij Airway Therapeutics, Inc.
Profiel
Alan S.
Wolk currently works at Jewish National Fund United States, as Director and Airway Therapeutics, Inc., as Chief Financial & Operating Officer.
Actieve functies van Alan S. Wolk
| Bedrijven | Functie | Begin |
|---|---|---|
Airway Therapeutics, Inc.
 Airway Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Airway Therapeutics, Inc. operates as a pharmaceutical company which specializes in the development of surfactant-related products. The firm offers products for the prevention of bronchopulmonary dysplasia, as well as for the treatment of pulmonary infections associated with cystic fibrosis. It also provides pediatric drug development, orphan drug development, pulmonary therapies, protein drug development, neonatal drug therapy, and inhalation drug delivery. The company was founded by Charles McOsker in 2011 and is headquartered in Cincinnati, OH. | Financieel Directeur/CFO | - |
Jewish National Fund United States
 Jewish National Fund United States Real Estate DevelopmentFinance Jewish National Fund United States develops Israeli land and infrastructure. It builds reservoirs and dams and also plants trees. The company was founded in 1901 and is headquartered in New York, NY. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Jewish National Fund United States
Jewish National Fund United States Real Estate DevelopmentFinance Jewish National Fund United States develops Israeli land and infrastructure. It builds reservoirs and dams and also plants trees. The company was founded in 1901 and is headquartered in New York, NY. | Finance |
Airway Therapeutics, Inc.
Airway Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Airway Therapeutics, Inc. operates as a pharmaceutical company which specializes in the development of surfactant-related products. The firm offers products for the prevention of bronchopulmonary dysplasia, as well as for the treatment of pulmonary infections associated with cystic fibrosis. It also provides pediatric drug development, orphan drug development, pulmonary therapies, protein drug development, neonatal drug therapy, and inhalation drug delivery. The company was founded by Charles McOsker in 2011 and is headquartered in Cincinnati, OH. | Health Technology |
